Febrile neutropenia (FN) is a significant concern in pediatric oncology, particularly for children undergoing chemotherapy. It occurs when a patient has a fever and a low number of neutrophils ...

A study from the University of Notre Dame and the Hospital Infantil de México Federico Gómez is evaluating the preliminary ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

We still have much to learn about neonatal neutropenia, but this is an encouraging ... assistant professor of pediatrics and a neonatologist who treats these hospitalized infants.

Late-onset neutropenia (LON) is emerging as a common adverse effect to rituximab therapy owing to widespread use of this drug in the treatment of B-cell lymphomas and autoimmune diseases.

Febrile neutropenia (FN) is a common and serious complication in pediatric oncology, particularly following chemotherapy. It occurs when a child has a fever and a significantly reduced number of ...